ORAVIG Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Oravig, and when can generic versions of Oravig launch?
Oravig is a drug marketed by Galt Pharms and is included in one NDA. There are three patents protecting this drug.
This drug has twenty-four patent family members in fourteen countries.
The generic ingredient in ORAVIG is miconazole. There are twenty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the miconazole profile page.
DrugPatentWatch® Generic Entry Outlook for Oravig
Indicators of Generic Entry
Summary for ORAVIG
International Patents: | 24 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 110 |
Patent Applications: | 4,057 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ORAVIG |
What excipients (inactive ingredients) are in ORAVIG? | ORAVIG excipients list |
DailyMed Link: | ORAVIG at DailyMed |


Pharmacology for ORAVIG
Drug Class | Azole Antifungal |
Anatomical Therapeutic Chemical (ATC) Classes for ORAVIG
US Patents and Regulatory Information for ORAVIG
ORAVIG is protected by three US patents.
Patents protecting ORAVIG
Prolonged release bioadhesive therapeutic systems
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF OROPHARYNGEAL CANDIDIASIS
Prolonged release bioadhesive therapeutic systems
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF OROPHARYNGEAL CANDIDIASIS
Prolonged release bioadhesive therapeutic systems
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galt Pharms | ORAVIG | miconazole | TABLET;BUCCAL | 022404-001 | Apr 16, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Galt Pharms | ORAVIG | miconazole | TABLET;BUCCAL | 022404-001 | Apr 16, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Galt Pharms | ORAVIG | miconazole | TABLET;BUCCAL | 022404-001 | Apr 16, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ORAVIG
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galt Pharms | ORAVIG | miconazole | TABLET;BUCCAL | 022404-001 | Apr 16, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Galt Pharms | ORAVIG | miconazole | TABLET;BUCCAL | 022404-001 | Apr 16, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Galt Pharms | ORAVIG | miconazole | TABLET;BUCCAL | 022404-001 | Apr 16, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ORAVIG
See the table below for patents covering ORAVIG around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Cyprus | 1107828 | ⤷ Try a Trial | |
European Patent Office | 1408911 | SYSTEMES THERAPEUTIQUES BIOADHESIFS A LIBERATION PROLONGEE (SUSTAINED-RELEASE THERAPEUTIC BIOADHESIVE SYSTEMS) | ⤷ Try a Trial |
Spain | 2294170 | ⤷ Try a Trial | |
France | 2827517 | SYSTEMES THERAPEUTIQUES BIOADHESIFS A LIBERATION PROLONGEE | ⤷ Try a Trial |
Japan | 4657603 | ⤷ Try a Trial | |
Austria | 373464 | ⤷ Try a Trial | |
Denmark | 1408911 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |